Skip to Content
Contact Form Map & Directions Videos

Category: Defective Drugs

Amylin Held Back Safety Data from FDA on Diabetes Drug

06/30/2012
Articles
BY

Documents recently posted to the FDA’s website say pharmaceutical company, Amylin, has not been completely forthcoming about its diabetes drug, Byetta, and related drug Bydureon, concerning their potential for cardiovascular complications. The active ingredient is the same in the two drugs which are both used to treat type 2 diabetes. However, Bydureon […]

Read More

Yet Another DePuy Lawsuit Filed

06/27/2012
Announcement
BY

  Another DePuy ASR hip implant lawsuit was filed this week against DePuy Orthopaedics and its parent company, Johnson & Johnson.  This lawsuit was filed on behalf of a 61 year old woman who lives on a farm near Gainesville, Florida.  She had the misfortune of being implanted with not […]

Read More

Pradaxa Tops FDA’s List for Serious Adverse Events

06/26/2012
Articles
BY

According to an analysis by the Institute for Safe Medication Practices, Pradaxa drug (Dabigatran) topped the list of direct reports to the FDA for serious adverse drug events in 2011.  Pradaxa took the lead with 817 direct reports, followed by Coumadin (Warfarin) with 490 direct reports, Levaquin (Levofloxacin) with 393, […]

Read More

Azithromycin & Sudden Cardiac Death

05/21/2012
Articles
BY

A study published in the New England Journal of Medicine on May 17, 2012, suggests that the popular antibiotic azithromycin may increase the risk of sudden cardiovascular death, especially among patients who are already at risk for cardiovascular disease.  Different patient groups were treated with azithromycin (Zithromax), amoxicillin, ciprofloxacin (Cipro), […]

Read More

Hear What Our Clients Have To Say

"Every question that I had was answered in mere minutes and the follow through that the staff, secretaries and attorneys had was superior. I have dealt with many, many firms that have all disappointed me and Searcy Denney was by far the most thorough - I highly recommend them!"
Posted By: Susan Baker